"With SomaFocus, you can potentially elucidate which neuronal cell type(s) are being affected by the disease or by a drug. That’s something you can’t do with MEA, and it’s incredibly valuable for drug discovery. One way to do this is by spike waveform analysis, for example, with very narrow action potentials representing parvalbumin-positive interneurons."
Stuart Lipton
Principal Investigator- Scripps Research Institute, Department of Molecular and Cellular Biology; Professor- Neurology, Yale School of Medicine